Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorgen Vestbo

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Medical Informatics and Decision Making|April 17, 2015
Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibilityHanaa F Elkhenini, Kourtney J Davis, Norman D Stein, et al.
ERJ Open Research|November 25, 2021
Impact of the UK lockdown on people at risk of COPDGavin C Donaldson, Andrew I Ritchie, Peter M A Calverley, et al.
Thorax|June 4, 2015
Microfibrillar-associated protein 4 modulates airway smooth muscle cell phenotype in experimental asthmaBartosz Pilecki, Anders Schlosser, Helle Wulf-Johansson, et al.
Human Molecular Genetics|March 18, 2008
Identification of a novel asthma susceptibility gene on chromosome 1qter and its functional evaluationJulia H White, Mathias Chiano, Mark Wigglesworth, et al.
COPD|May 30, 2013
The COPD Biomarker Qualification Consortium (CBQC)Richard Casaburi, Bartolome Celli, James Crapo, et al.
ERJ Open Research|July 29, 2021
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trialEmily P Brigham, Julie A Anderson, Robert D Brook, et al.
ERJ Open Research|August 23, 2023
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPDClaire Bradley, Panos Alexandris, David R Baldwin, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 17, 2015
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPDDavid M Mannino, Ruth Tal-Singer, David A Lomas, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Medical Informatics and Decision Making|April 17, 2015
Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibilityHanaa F Elkhenini, Kourtney J Davis, Norman D Stein, et al.
ERJ Open Research|November 25, 2021
Impact of the UK lockdown on people at risk of COPDGavin C Donaldson, Andrew I Ritchie, Peter M A Calverley, et al.
Thorax|June 4, 2015
Microfibrillar-associated protein 4 modulates airway smooth muscle cell phenotype in experimental asthmaBartosz Pilecki, Anders Schlosser, Helle Wulf-Johansson, et al.
Human Molecular Genetics|March 18, 2008
Identification of a novel asthma susceptibility gene on chromosome 1qter and its functional evaluationJulia H White, Mathias Chiano, Mark Wigglesworth, et al.
COPD|May 30, 2013
The COPD Biomarker Qualification Consortium (CBQC)Richard Casaburi, Bartolome Celli, James Crapo, et al.
ERJ Open Research|July 29, 2021
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trialEmily P Brigham, Julie A Anderson, Robert D Brook, et al.
ERJ Open Research|August 23, 2023
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPDClaire Bradley, Panos Alexandris, David R Baldwin, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 17, 2015
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPDDavid M Mannino, Ruth Tal-Singer, David A Lomas, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Pageof 4